Form 4: Pfizer SVP & Controller Jennifer B. Damico Reports Stock Transactions

Jennifer B. Damico, SVP & Controller of Pfizer Inc., reports the earn-out of stock appreciation rights and withholding of shares to cover tax obligations and exercise price.

Summary

• On February 23, 2024, Jennifer B. Damico, SVP & Controller of Pfizer Inc., engaged in several transactions involving Pfizer common stock.
• These transactions included the earn-out of 9,752 stock appreciation rights at a price of $27.34.
• Additionally, shares were withheld to satisfy tax obligations upon the vesting of restricted stock units and in connection with the earn-out of stock appreciation rights.
• Shares were also withheld to cover the payment of the exercise price in connection with the earn-out of stock appreciation rights.
• The price of the common stock on February 23, 2024, was $27.76.
• Further transactions involving withholding of shares for tax obligations occurred on February 24 and February 25, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock transactions by an insider, which is a routine occurrence.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel and their holdings in the company.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders as they represent routine insider trading activity.

Key Dates